Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
Immunotherapy
Tag: Immunotherapy
Biotechnology
What Did European Oncology Players Offer at ASCO 2020?
BioChannel
-
June 3, 2020
Biotechnology
French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy
BioChannel
-
May 28, 2020
Biotechnology
iTeos Therapeutics’ Cancer Immunotherapy Boosted with €114M Funding
BioChannel
-
April 2, 2020
Biotechnology
This Startup Hits Hidden Proteins to Make Cancer Immunotherapies
BioChannel
-
March 13, 2020
Biotechnology
Bicycle Therapeutics Partners Genentech in Deal Worth €1.6B
BioChannel
-
February 26, 2020
Biotechnology
This Cancer Immunotherapy Attacks the Sugar Coat of Tumor Cells
BioChannel
-
January 31, 2020
Biotechnology
UK Startup Snaps up Potential Universal Cancer Immunotherapy
BioChannel
-
January 27, 2020
Biotechnology
French Biotech Raises €19M to Hit Phase I with Cancer Immunotherapy
BioChannel
-
January 9, 2020
Biotechnology
Update: Cancer Immunotherapy Biotech Files for Insolvency
BioChannel
-
December 6, 2019
Biotechnology
GammaDelta Therapeutics Spins Out Cancer Immunotherapy Biotech
BioChannel
-
October 16, 2019
1
2
3
Page 1 of 3
Stay connected
49,060
Followers
Follow
14,700
Subscribers
Subscribe
Recent posts
Life in the Time of Coronavirus
BioChannel
-
July 10, 2020
Study pinpoints brain cells that trigger sugar cravings and consumption
BioChannel
-
July 10, 2020
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
BioChannel
-
July 10, 2020
Random article
Life in the Time of Coronavirus
Study pinpoints brain cells that trigger sugar cravings and consumption
Life Sciences Fund Launches with €76M to Invest in Nordic Biotech
VarmX bags €32m in Series B round – European Biotechnology News
Edit with Live CSS